Shared publicly  - 
Xconomy: Alder Biopharma Snags $38M To Charge Ahead With Antibody Drugs
Alder Biopharmaceuticals has nailed down the biggest round of venture capital the Seattle biotech community has seen in a long time. The Bothell, WA-based
Laura Strong's profile photoKevin Chow's profile photo
Thanks again, Laura! Excited to have Novo involved now.
Add a comment...